A New Framework for Evaluating the Potential for Drug Law to Produce Stigma: Insights from an Australian Study

Abstract

Alcohol and other drug-related stigma is a growing concern. Many organizations have called for a reduction in such stigma through law reform, but there is little sense of how, precisely, this might be achieved. This paper reports on a new method to examine the relationship between stigma and the law and establish a framework that can guide and inform future law reform efforts.

Get full access to this article

View all access options for this article.

References

Goffman

, Stigma: Notes on the Management of Spoiled Identity (New York: Prentice Hall 1963): at 3.

Goffman, supra note 1: at 13.

Goffman, supra note 1: at 12.

B.G.

Link and

J.C.

Phelan , “Conceptualizing Stigma,” Annual Review of Sociology 27 (2001) 363-385.

Room

, “Stigma, Social Inequality and Alcohol and Drug Use,” Drug and Alcohol Review 24, no. 2 (2005): 143-155.

AIVL, Why Wouldn’t I Discriminate Against All of Them?” A Report on Stigma and Discrimination Towards the Injecting Drug User Community (Canberra: Australian Injecting and Illicit Drug Users League, 2011);

P.W.

Corrigan ,

S.A.

Kuwabara and

O’Shaughnessy , “The Public Stigma of Mental Illness and Drug Addiction: Findings from a Stratified Random Sample,” Journal of Social Work 9, no. 2, (2009): 139-147;

Lloyd

, Sinning and Sinned Against: The Stigma-tisation of Problem Drug Users (London: UK Drug Policy Commission (UKDPC), 2010);

Lloyd

, “The Stigmatization of Problem Drug Users: A Narrative Literature review,” Drugs: Education, Prevention, and Policy 20, no. 2 (2013): 85-95;

Radcliffe and

Stevens , “Are Drug Treatment Services Only for ‘Thieving Junkie Scumbags?’ Drug Users and the Management of Stigmatised Identities,” Social Science & Medicine 67, no. 7 (2008): 1065-1073;

Simmonds and

Coomber , “Injecting Drug Users: A Stigmatised and Stigmatising Population,” International Journal of Drug Policy 20, no. 2 (2009): 121-130; UKDPC, Getting Serious About Stigma: The Problem with Stigmatising Drug Users (London: UK Drug Policy Commission (UKDPC), 2010).

Lloyd, supra note 6.

UKDPC, supra note 6.

Lloyd, supra note 6 (2013).

10.

J.L.

Fitzgerald ,

McDonald and

Klugman , Unspoken but Everpresent: Hepatitis C in a Regional Setting (Melbourne: University of Melbourne, 2004).

11.

United Nations Office on Drugs and Crime, World Drug Report 2008, available at <https://www.unodc.org/documents/wdr/WDR_2008/WDR_2008_eng_web.pdf>, at 216 (last visited November 13, 2017).

12.

United Nations Office on Drugs and Crime, World Drug Report 2016 (United Nations publication, Sales No. E.16. XI.7), available at <https://www.unodc.org/doc/wdr2016/WORLD_DRUG_REPORT_2016_web.pdf> (last visited November 13, 2017); see also UNAIDS, Do No Harm: Health, Human Rights, and People Who Use Drugs (New York, UNAIDS, 2016).

13.

World Health Assembly, Resolution on Viral Hepatitis 2010, WHA 67.6.

14.

World Health Organization, Global Health Sector Strategy on Viral Hepatitis 2016-2021: Towards Ending Viral Hepatitis (Geneva: World Health Organization, 2016): at 42.

15.

World Health Organisation, supra note 14, at 42.

16.

Ministerial Council on Drug Strategy, National Drug Strategy 2010-2015: A Framework for Action on Alcohol, Tobacco and Other Drugs, 2011 (Canberra: Commonwealth of Australia; 2011).

17.

At the time of writing, Australia’s next National Drug Strategy was still under development.

18.

Commonwealth of Australia, Fourth National Hepatitis C Strategy, 2014-2017 (Canberra, Australia, 2014): at 6.

19.

Goffman, supra note 1, at 3.

20.

Goffman, supra note 1, at 3-4.

21.

Goffman, supra note 1, at 4.

22.

Fraser and

Valentine , Substance and Substitution: Methadone Subjects in Liberal Societies (Basingstoke: Palgrave Macmillan, 2008);

Fraser and

Seear , Making Disease, Making Citizens: The Politics of Hepatitis C (Aldershot: Ash-gate, 2011).

23.

Nussbaum

, Hiding from Humanity: Disgust, Shame and the Law (Princeton: Princeton University Press, 2004).

24.

Burris

, “Stigma and the Law,” The Lancet 367, no. 9509 (2006): 529-531.

25.

Room, supra note 5, at 147-148. See also,

Buchanan

, “Tackling Problem Drug Use: A New Conceptual Framework,” Social Work in Mental Health 2, no. 2–3 (2004) 117–138;

Buchanan and

Young , “The War on Drugs — A War on Drug Users?” Drugs: Education, Prevention and Policy 7, no. 4 (2000) 409–422.

26.

See, for example <http://www.countthecosts.org/sites/default/files/Stigma-briefing.pdf> (last visited November 13, 2017).

27.

UNODC, supra note 12, at 99-100.

28.

See, for example,

Ahmed

, The Cultural Politics of Emotion, 2nd ed. (New York: Routledge 2015);

Butler

, Excitable Speech: A Politics of the Performative (New York: Routledge 1997).

29.

<https://www.whitehouse.gov/sites/whitehouse.gov/files/images/Memo%20-%20Changing%20Federal%20Terminology%20Regrading%20Substance%20Use%20and%20Substance%20Use%20Disorders.pdf> (last visited November 13, 2017).

30.

Problematic terminology remains in use in drug law and drug policy, however, and at times is used by lawyers, sitting magistrates and judges. See,

Seear and

Fraser , “Addiction Veri-diction: Gendering Agency in Legal Mobilisations of Addiction Discourse,” Griffith Law Review 25, no. 1 (2016): 13-29;

Seear and

Fraser , “Beyond Criminal Law: The Multiple Constitution of Addiction in Australian Legislation,” Addiction Research & Theory 22, no. 5 (2014a): 438-450;

Seear and

Fraser , “The Addict as Victim: Producing the ‘Problem’ of Addiction in Australian Victims of Crime Compensation.” International Journal of Drug Policy 25, no. 5 (2014b): 826–835.

31.

Seear and Fraser, supra note 30 (2014a).

32.

Seear and Fraser, supra note 30 (2014a).

33.

Mol

, The Body Multiple: Ontology in Medical Practice (Durham: Duke University Press, 2002).

34.

Room, supra note 5, at 150.

35.

Room, supra note 5, at 150.

36.

Room, supra note 5, at 150.

37.

Room, supra note 5, at 150.

38.

Burris, supra note 24, at 530.

39.

Sunstein

, “On the Expressive Function of Law,” University of Pennsylvania Law Review 144 (1996): 2021-2024, at 2025.

40.

Bacchi

, Analysing Policy: What’s the Problem Represented to Be? (Sydney: Pearson Education, 2009).

41.

Seear and Fraser, supra note 30 (2014a).

42.

Fraser ,

Pienaar ,

Dilkes-Frayne ,

Moore ,

Kokanovic ,

Treloar , and

Dunlop , “Addiction Stigma and the Biopolitics of Liberal Modernity: A Qualitative Analysis,” International Journal of Drug Policy 44 (2017): 192-201.

43.

Link and Phelan, supra note 4, at 366.

44.

Link and Phelan, supra note 4.

45.

Simmonds and Coomber, supra note 6.

46.

Fraser et al., supra note 43.

47.

Kleinman and

Hall-Clifford , “Stigma: A Social, Cultural and Moral Process,” Journal of Epidemiology and Community Health 63, no. 6 (2009): 418-419; Link and Phelan, supra note 4.

48.

Butler

, “Performative Agency,” Journal of Cultural Economy 3, no. 2 (2010): 147;

Butler

, Bodies that Matter: On the Dis-cursive Limits of “Sex” (New York: Routledge, 1993);

Butler

, Gender Trouble: Feminism and the Subversion of Identity (New York: Routledge, 1990).

49.

Race

, “Framing Responsibility: HIV, Biomedical Prevention, and the Performativity of the Law,” Bioethical Inquiry 9, no. 3 (2012): 327-338 at 328.

50.

Law

, “Collateral Realities,” The Politics of Knowledge (London: Routledge, 2011) at 156.

51.

J. Stone

Peters

, “Legal Performance Good and Bad,” Law, Culture and the Humanities 4, no. 2 (2008): 179-200.

52.

Butler, supra note 48 (1990).

53.

Race, supra note 49.

54.

Fraser and

Moore , (eds) The Drug Effect: Health, Crime and Society (Melbourne: Cambridge University Press, 2011).

55.

Fraser et al., supra note 42.

56.

Butler, supra note 48 (1993): at 3.

57.

Goffman, supra note 1, at 155.

58.

Fraser et al., supra note 42, at 195.

59.

Fraser et al., supra note 42, at 199.

60.

The authors also recognize the possibility for stigma to be associated with what they call “specific enactments of intoxication.”

61.

Race, supra note 49, at 328.

62.

Race, supra note 49, at 328.

63.

Race

, “Drug Effects, Performativity and the Law,” International Journal of Drug Policy 22, no. 6 (2011): 410-412, at 411.

64.

P.W.

Corrigan ,

A.C.

Watson ,

A.C.

Heyrman ,

Warpinski ,

Gracia ,

Slopen , et al.

“Structural Stigma in State Legislation,”

Psychiatric Services 56, no. 5 (2005): 557-563.

65.

Corrigan et al., supra note 64, at 557.

66.

Corrigan et al., supra note 64, at 558.

67.

Corrigan et al., supra note 64, at 558.

68.

Quilter ,

McNamara ,

Seear , and

Room , “Alcohol and Drug Use and Criminal Law: A National Study of the Significance of “Intoxication” Under Australian legislation,” UNSW Law Journal 39, no. 3 (2016a): 913-949;

Quilter ,

McNamara ,

Seear , and

Room , “The Definition and Significance of ‘Intoxication in Australian Criminal Law: A Case Study of Queensland’s ‘Safe night out’ legislation,” QUT Law Review 16, no. 2 (2016b): 42-58.

69.

Fraser et al., supra note 42.